Super-enhancer RNA m 6 A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma

Rui Li,Hongzhe Zhao,Xudong Huang,Jialiang Zhang,Ruihong Bai,Lisha Zhuang,Shujuan Wen,Shaojia Wu,Quanbo Zhou,Mei Li,Lingxing Zeng,Shaoping Zhang,Shuang Deng,Jiachun Su,Zhixiang Zuo,Rufu Chen,Dongxin Lin,Jian Zheng
DOI: https://doi.org/10.1038/s41588-023-01568-8
IF: 30.8
2023-11-14
Nature Genetics
Abstract:The biological functions of noncoding RNA N 6 -methyladenosine (m 6 A) modification remain poorly understood. In the present study, we depict the landscape of super-enhancer RNA (seRNA) m 6 A modification in pancreatic ductal adenocarcinoma (PDAC) and reveal a regulatory axis of m 6 A seRNA, H3K4me3 modification, chromatin accessibility and oncogene transcription. We demonstrate the cofilin family protein CFL1, overexpressed in PDAC, as a METTL3 cofactor that helps seRNA m 6 A methylation formation. The increased seRNA m 6 As are recognized by the reader YTHDC2, which recruits H3K4 methyltransferase MLL1 to promote H3K4me3 modification cotranscriptionally. Super-enhancers with a high level of H3K4me3 augment chromatin accessibility and facilitate oncogene transcription. Collectively, these results shed light on a CFL1–METTL3–seRNA m 6 A–YTHDC2/MLL1 axis that plays a role in the epigenetic regulation of local chromatin state and gene expression, which strengthens our knowledge about the functions of super-enhancers and their transcripts.
genetics & heredity
What problem does this paper attempt to address?